Veristat Appoints Rachel Page as Chief Commercial Officer and Cindy Henderson as Chief Strategy Officer
Position
Chief Strategy Officer
Company
Veristat
SouthboroughBiotechnologyHealth CareTherapeuticsDescription
Veristat announced the appointment of Rachel Page as Chief Commercial Officer, succeeding Cindy Henderson who transitioned to become Chief Strategy Officer. Rachel's extensive experience in global health and science commercialization will be crucial in assisting biopharmaceutical companies in navigating complex clinical and regulatory challenges. Cindy Henderson will focus on developing and executing Veristat’s customer-driven corporate strategy.
Quick answer
Veristat Appoints Rachel Page as Chief Commercial Officer and Cindy Henderson as Chief Strategy Officer (May 23, 2024). Veristat is based in Southborough, Massachusetts, United States.
- Who is the new Chief Strategy Officer at Veristat?
- Veristat named Cindy Henderson Chief Strategy Officer, announced May 23, 2024.
- What did Veristat announce on May 23, 2024?
- Veristat announced the appointment of Rachel Page as Chief Commercial Officer, succeeding Cindy Henderson who transitioned to become Chief Strategy Officer. Rachel's extensive experience in global health and science commercialization will be crucial in assisting biopharmaceutical companies in navigating complex clinical and regulatory challenges.
- What does Veristat do?
- Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel...
- Where is Veristat based?
- Veristat is based in Southborough, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Crispr Therapeutics (May 24, 2024), Oragenics (May 22, 2024), Atalanta Therapeutics (May 22, 2024) and Kronos Bio (May 21, 2024) also announced leadership changes within 45 days of Veristat.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer (May 24, 2024)
- Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial (May 22, 2024)
- Atalanta Therapeutics Appoints Serena Hung as Chief Medical Officer and Jeffrey Young as Chief Financial Officer (May 22, 2024)
- Kronos Bio Appoints Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer (May 21, 2024)
- Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer (May 20, 2024)
- HaemaLogiX Appoints Professor the Hon Greg Hunt as Non-Executive Director (May 20, 2024)
Who to call at Veristat, and when
A new leader at Veristat brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Veristat raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Veristat, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Veristat. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Veristat changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Veristat changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.